Amwill Health Care Board Re-appoints MDs, Approves FY26 Annual Report
BOARD
▲ Positive Development
LOW RISK
📅 Filed on BSE: 17 Jul 2026, 04:29 PM IST · BSE ID: 9c95e280-4acb-4ea6-8630-26de3f4f54dc
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors have re-appointed two key managing directors and approved the annual report for the past fiscal year.
🤖 AI Summary
- Board re-appointed Mr. Tarun Gandhi as MD for 5 years starting Jan 27, 2027.
- Board re-appointed Mr. Anand Gandhi as MD for 5 years starting Jan 27, 2027.
- Both re-appointments are subject to shareholder approval via special resolution.
- Annual Report for financial year 2025-26 was approved by the Board.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Managing Director Re-appointment Period
05 (five) years
Re-appointment Commencement Date
January 27, 2027
Re-appointment End Date
January 26, 2032
Financial Year of Annual Report
2025-26
🏢 How This Affects the Company
Re-appointment of key managerial personnel provides continuity in leadership and strategic direction.
Approval of the Annual Report signifies the finalization of the company's financial performance for FY2025-26.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to vote on the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi via special resolution at the upcoming AGM.
👤
Who Is Affected
All shareholders will be affected as the re-appointments are subject to their approval by special resolution at the AGM.
🔍
Management Signal
The decision signals management's intent to retain experienced leadership for the next five years.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder voting at the 9th Annual General Meeting on MD re-appointments.
Company's upcoming quarterly financial results for Q1 FY27.
Disclosure of audited financial statements for FY2025-26.
LOW RISK
Board meeting outcome focuses on leadership continuity and routine annual report approval.
💡 Investor Takeaway
Amwill Health Care's board re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five years, subject to shareholder approval, and approved the FY2025-26 Annual Report.
❓ Frequently Asked Questions
Who has been re-appointed as Managing Director at Amwill Health Care?
Mr. Tarun Gandhi and Mr. Anand Gandhi have been re-appointed as Managing Directors for a period of 05 (five) years.
What is the tenure for the re-appointed Managing Directors at Amwill Health Care?
The re-appointment is for a period of consecutive 05 (five) years, commencing from January 27, 2027 till January 26, 2032.
What needs to happen for the MD re-appointments to be effective?
The re-appointments are subject to the approval of the shareholders of the Company by way of special resolution at the ensuing 09th Annual General Meeting.
What annual report has Amwill Health Care's board approved?
The Board of Directors has approved the Annual Report for the financial year 2025-26.
Questions based on this BSE filing only. For information purposes.